The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
- PMID: 32194995
- PMCID: PMC7060195
- DOI: 10.1038/s41541-020-0170-0
The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
Abstract
The outbreak of 2019-novel coronavirus disease (COVID-19) that is caused by SARS-CoV-2 has spread rapidly in China, and has developed to be a Public Health Emergency of International Concern. However, no specific antiviral treatments or vaccines are available yet. This work aims to share strategies and candidate antigens to develop safe and effective vaccines against SARS-CoV-2.
Keywords: Infection; Microbiology; Pathogenesis; Vaccines.
© The Author(s) 2020.
Conflict of interest statement
Competing interestsThe authors declare no competing interests.
References
-
- National Health Commission of the People’s Republic of China. Epidemic Prevention and Control of Dynamic. http://www.nhc.gov.cn/xcs/yqtb/202002/ac1e98495cb04d36b0d0a4e1e7fab545.s.... - PMC - PubMed
-
- Guan, W. et al. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv.10.1101/2020.02.06.20020974 (2020).
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
